10.21147/j.issn.1000-9604.2022.04.03
Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer
advanced、clinical、cancer、breast、decisions、endocrine、guiding、her-2-negative、hr-positive、next-generation
34
R6;TN929.531;G2
2022-10-11(万方平台首次上网日期,不代表论文的发表时间)
共10页
343-352